Ditchcarbon
  • Contact
  1. Organizations
  2. Lupin
Public Profile
Pharmaceutical Preparation Manufacturing
IN
updated a month ago

Lupin Sustainability Profile

Company website

Lupin Limited, commonly referred to as Lupin, is a prominent global player in the pharmaceutical industry, headquartered in Mumbai, India. Founded in 1968, the company has established a strong presence in key operational regions, including North America, Europe, and Asia. Lupin is renowned for its diverse portfolio, which encompasses generic and branded formulations, biotechnology products, and active pharmaceutical ingredients (APIs). With a commitment to innovation, Lupin has achieved significant milestones, including numerous approvals from regulatory authorities worldwide. The company is particularly noted for its leadership in the anti-TB and cardiovascular segments, offering unique products that cater to unmet medical needs. As a result, Lupin has secured a competitive market position, consistently ranking among the top generic pharmaceutical companies globally.

DitchCarbon Score

How does Lupin's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

51

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Lupin's score of 51 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.

68%

Let us know if this data was useful to you

Lupin's reported carbon emissions

In 2024, Lupin reported total greenhouse gas emissions of approximately 61474000 kg CO2e for Scope 1, 263905000 kg CO2e for Scope 2, and 901520000 kg CO2e for Scope 3, amounting to a total of about 1220000000 kg CO2e globally. In 2023, the emissions were approximately 86910000 kg CO2e (Scope 1), 323845000 kg CO2e (Scope 2), and 854936000 kg CO2e (Scope 3), resulting in a total of about 1260000000 kg CO2e. In India, for 2023, Lupin's emissions included approximately 87068000 kg CO2e (Scope 1), 340945000 kg CO2e (Scope 2), and 651664000 kg CO2e (Scope 3), totalling around 428013000 kg CO2e for Scope 1 and 2 combined. The previous year, 2022, saw similar figures with approximately 86175000 kg CO2e (Scope 1), 380306000 kg CO2e (Scope 2), and 676018000 kg CO2e (Scope 3), leading to a combined total of about 466481000 kg CO2e for Scope 1 and 2. Lupin has set an ambitious target to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 15% by 2030, starting from 2021. This commitment reflects the company's proactive approach to addressing climate change and aligns with industry standards for emissions reduction. Additionally, Lupin is a signatory to the Climate Pledge, further demonstrating its commitment to sustainability and climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
103,887,000
000,000,000
00,000,000
00,000,000
00,000,000
Scope 2
371,883,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
680,968,000
000,000,000
000,000,000
000,000,000
000,000,000

How Carbon Intensive is Lupin's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Lupin's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Lupin's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Lupin is in IN, which has a very high grid carbon intensity relative to other regions.

Lupin's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Lupin has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Lupin's Emissions with Industry Peers

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Dr Reddys Laboratories

IN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Pfizer Limited

IN
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Sandoz International GmbH

DE
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Frequently Asked Questions

Common questions about Lupin's sustainability data and climate commitments

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251117.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy